| 
 Horiba Is Working On The Biggest Medical 
Factory In India: Dr Jai Hakhu, Chairman And CEO, Horiba 
In near future healthcare will have monitors, electronic 
sensors at home and the doctors will know proactively that what is going on. 
Some kind of predictive health messages will be sent ahead of time. The devices 
which we make, in the future, will have wifi connectivity or Bluetooth, so you 
don't have to visit a doctor to find out what happened, it can simply be done by 
phone. 
Shahid Akhter, editor, ETHealthworld, spoke to Dr Jai Hakhu, 
Chairman and CEO, Horiba, Instruments Incorporated (U.S), 
President of Horiba, to know more about Horiba's contribution in the field of 
blood analyzers and their plans to scale up manufacturing in India. 
Global healthcare technology: Trends 
The key thing now is remote connectivity because the next 
step in healthcare will be that you will have monitors, electronic sensors at 
your home and the doctors will know proactively that what is going on. For 
example, in diabetic people where you must have seen that they can have 
continuous monitoring and that is monitored by a doctor's office. There is no 
point that people will get a big shock or stroke as some kind of predictive 
messages will be sent ahead of time. Big data is going to be very important in 
the medical field. The devices which we make, in the future, will have wifi 
connectivity or Bluetooth, so you don't have to visit a doctor to find out what 
happened, it can simply be done by phone. Hence. these trends are emerging. 
Global healthcare technology: Market 
People get sick in both poor or rich countries, so our job is 
to reduce the cost per test. As far as India is concerned, I want to reach every 
corner of the country. We have about 12 acres of land in Nagpur and the building 
is being built right now. The idea is to reach every place at affordable cost 
and also our goal is to help the society. 
Global/Indian healthcare technology: Horiba Medicals 
Horiba is not the biggest in healthcare, there are many other 
big companies, but Horiba has the analyzers right from the Founder. If you look 
at the broad cross-section of Horiba, there is a common thing called analyzers. 
In healthcare, you are analyzing the blood and we are focusing on the analysis 
part of the healthcare. 
For example, we introduced the Helo product for healthcare. 
It is a track system that was introduced around two-three months back in India 
and it was accepted by Zeimens as a standard product. They will be using our 
product globally, so it's not only what we do, but also what we can do with 
others. Therefore analyzing is the key part. 
I started Horiba India Healthcare around eight-nine years 
back. We were two people and our position through distributors was number fifth. 
Our goal to be number three and team of Horiba India achieved it. Now, we are 
almost number one in the field of blood analyzers. 
Global healthcare delivery system: Your views 
Different countries have different health systems. For 
example, in the US healthcare system is not that good. It depends on how much 
money you make. Similarly, if you go to Canada everybody gets healthcare or even 
in England, but we have to do a lot of work. In China, I visited hospitals and 
was very disturbed to see that healthcare does not reach the poorest section. We 
have a tremendous disparity, even in India. We need to work on that as to how we 
can normalise it and reduce the cost per test so that we can serve the masses. 
Therefore it's not in the great state globally. 
Horiba Medicals: Future plans for India 
We are building twelve acres complex in Nagpur and it will 
have a capacity for us to serve for the next ten to fifteen years. We have also 
invested in Haridwar and Pune. It's going to be the biggest medical factory in 
India. My personal goal is to reach the masses at an affordable cost, but we 
have to make money to keep on investing. 
Make in India: Ease of doing business 
We need to have manufacturing in India, not only that but 
also the supply chain as manufacturing alone is simply not the answer. As what 
happens in the labour for manufacturing is only ten percent, you don't gain much 
as you have to develop the infrastructure. 
https://health.economictimes.indiatimes.com/news/industry/weare-working-on-the-biggest-medical-factory-in-india-dr-jaihakhu-chairman-and-ceo-horiba/72973637 
 
Indian Market Full Of 
Unauthentic Certificates For QMS In Medical Devices: Experts 
Even as concerns have been raised globally about counterfeit 
or unsafe medical devices, accreditation experts in India say that a large 
number of certificates of certification for quality management system (QMS) as 
per international standard, ISO 13485, in medical devices are unauthentic or 
fake. 
In India, certification bodies should be accredited by 
National Accreditation Board for Certification Bodies (NABCB) for undertaking 
certification as per ISO 13485 which is an international standard for QMS in 
medical devices and accepted by many regulators around the world. 
NABCB provides accreditation to certification and inspection 
bodies based on assessment of competence as per the applicable international 
standards and guidelines. 
It is internationally recognised and represents the interests 
of the Indian industry at international forums through membership and active 
participation with the objective of becoming a signatory to international 
multilateral / mutual recognition arrangements (MLA/MRA). 
It is also a member of International Accreditation Forum (IAF), 
International Laboratory Accreditation Cooperation (ILAC) and Asia Pacific 
Accreditation Cooperation (APAC) as well as signatory to its MRAs for QMS and 
product certification. 
Experts reason out that there is no ban on foreign 
accreditation bodies which might be members of IAF operating in India. IAF is 
the only international system of equivalence of certifications but is voluntary 
in nature and not obligatory. Therefore, there is no regulatory oversight on 
unauthentic or fake certificates. 
There are many certifying bodies in the Indian market which 
are either not accredited or are accredited by accreditation bodies which are 
not members of IAF and are issuing unauthentic certificates. They are also 
issuing certificates for CE mark, which is the European regulatory mark, without 
any accreditation or authorisation while only notified bodies of European 
Commission can issue such certificates. 
“There is no law which requires certification bodies to go 
for accreditation or be under the IAF system. That is why there are 
certification bodies which claim accreditation from some accreditation body 
which is not part of IAF. NABCB is member of IAF and has signed MRAs for 
different schemes,” informs Anil Jauhri, former CEO, NABCB. NABCB is a MRA 
signatory for ISO 17021 which covers QMS for medical devices under a broader 
framework, Jauhri further explains. 
List of NABCB-accredited certification bodies for ISO 13485 
for Medical Devices Quality Management Systems (MDQMS) are International 
Certifications Services Private Ltd, TUV SUD South Asia Pvt Ltd, Intertek India 
Pvt Ltd , TUV Rheinland (India) Pvt Ltd, DNV GL Business Assurance India Pvt 
Ltd, BSI Group India Pvt Ltd, TUV India Pvt Ltd, BSCIC Certifications Pvt Ltd, 
TUV InterCert Saar India Pvt Ltd, Zenith Quality Assessors Pvt Ltd and SGS India 
Pvt. Ltd. 
CDSCO notifies certification bodies under Medical Device 
Rules (MDR) -2017 based on NABCB accreditation only and only 6 of the above have 
been notified till now. 
The world market is full of private certification bodies 
issuing certificates to industry and it is important to distinguish an authentic 
certificate from many unauthentic, fake or fraudulent certificates going around. 
An authentic certificate should contain the following like 
name and address of the organisation certified, scope of certification 
describing its activities under certification, standard (or sometimes scheme or 
regulation) against which certification is granted e.g. ISO 9001 or ISO 22000 
(standard) or AS 9100 or FSSC 22000 (scheme). In general guidance standards are 
not amenable to certification. These have to be formal requirement standards or 
specifications. 
The authentic certificate should also include date of issue 
and expiry of certificate, unique identification number of the certificate, name 
and address of the certification body (CB), logo of the certification body, 
accreditation symbol indicating the name of the accreditation body (AB) which 
has accredited the certification body (in most countries, 
in the absence of any law requiring certification bodies to register, 
accreditation is the only way of recognizing a competent, authentic 
certification body). 
It should also include IAF Mark – indicating that the 
certificate is covered under the Multilateral Mutual Recognition Arrangement 
(MLA) of the International Accreditation Forum (IAF) and hence is 
internationally equivalent and acceptable in the market. 
In order to judge authenticity, the names of member ABs of 
IAF can be seen on its website www.iaf.nu. It also gives information on which 
accreditation bodies are signatories to IAF MLAs for specific schemes – QMS or 
EMS or FSMS. 
Once manufacturer locates the AB in a country, he can go to 
its website from the link given on IAF website and then on AB’s website to 
verify if the CB is accredited. 
“Then from the CB, you can verify the certificate because 
under international norms, CBs are obliged to help verify certificates issued by 
them. In case the certificate is issued under a scheme like IATF 16949 or AS 
9100, it is possible to verify the certificate through the scheme owners also,” 
Experts conclude. 
http://pharmabiz.com/NewsDetails.aspx?aid=120130&sid=1 
           |